Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

• Váldodahkkit: R. Cattaneo (Dahkki), M. Ferrari (Dahkki), S. Archetti (Dahkki), L. Andreoli (Dahkki), M. Taraborelli (Dahkki), A. Tincani (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: PAGEPress Publications, 2011-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Methotrexate is still a mainstay of rheumatoid arthritis treatment, but a significant variability in drug response is observed among patients. It has been proposed that C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase (MTHFR), an enzyme involved in the folate pathway, could be r...